Skip to main content
Caplight Logo









Orange Biomed

Orange Biomed

Private
SeoulHealthcare & Life Scienceshttps://orangebiomed.com/

Last Round

Series A

Extension

Dec 10, 2024

Total Funding Raised

$3.51M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Orange Biomed is a healthcare technology company that develops portable, microfluidic-based devices for measuring glycated hemoglobin (A1c) levels to improve diabetes management.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

HbA1c testingpoint-of-care testingmicrofluidicsdiabetes managementmedical deviceat-home testingPOCTdiagnostic hardwaredigital healthremote patient monitoringRPMhealth techdiagnostic equityMEMS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orange Biomed Comparables

Compare Orange Biomed with similar companies based on industry and business-model similarity.

Orange Biomed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sinocare Inc.
74%
Danaher Corporation
73%
AstraZeneca
73%

Orange Biomed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionDec 10, 2024
Early FundingAug 10, 2022

Orange Biomed Investors

Notable investors and investment history

Orange Biomed investors
InvestorRounds
K2 Investment PartnersSeries A Extension
Digital Healthcare PartnersEarly Funding
디지털 헬스케어 파트너스Early Funding
Seoul New Technology Investment Co.Early Funding
Intops InvestmentEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 307% MoM to 3.2K.

  • Nov 10, 2025

    Will attend MEDICA 2025 to showcase A1C test.

Orange Biomed Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orange Biomed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orange Biomed's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range13
Year Founded2021
Last FundingDec 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?